Burning Rock Biotech Limited - American Depositary Shares (BNR)

  Burning Rock Biotech (NASDAQ:BNR) reported its Q2 earnings results on Wednesday, August 31, 2022 at 05:30 AM. Here's what investors need to know about the announcement.

Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in milestones, plus tiered royalties.

Burning Rock Biotech just reported results for the first quarter of 2024.

These AI stocks cover voice, logistics, and videos, and all of them are trading at a decent discount to their real value.

Burning Rock Biotech just reported results for the fourth quarter of 2023.

Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its third quarter. • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.45 per share on revenue of $249.41 million.

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its first quarter.

Pre-market stock movers are a hot topic among traders this morning as we cover all of the biggest news moving shares on Wednesday!

Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.

U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.

 

 

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 100 points on Wednesday

Gainers

Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-risk postoperative coronary artery bypass grafting patients.